Related Experiment Videos
Antithrombin III in surgery
1Department for Blood Coagulation Disorders, University Surgical Clinic, Hamburg-Eppendorf, FRG.
Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1988
Summary
Monitoring Antithrombin III (AT III) levels and replacement therapy are crucial in high-risk patients to prevent blood clots. Prompt AT III replacement can avert life-threatening thromboembolic complications.
Area of Science:
- Biochemistry
- Hematology
- Critical Care Medicine
Background:
- Thromboembolic complications pose significant risks in perioperative and trauma settings.
- Antithrombin III (AT III) plays a vital role in regulating coagulation.
- AT III levels can be compromised by severe illness, trauma, and liver dysfunction.
Purpose of the Study:
- To highlight the importance of monitoring Antithrombin III (AT III) levels.
- To emphasize the role of AT III replacement therapy in preventing thromboembolic events.
- To identify critical clinical scenarios requiring AT III management.
Main Methods:
- Clinical monitoring of AT III values.
- Assessment of AT III deficiency causes (turnover vs. synthesis).
- Implementation of AT III replacement therapy when indicated.
Main Results:
- AT III monitoring and replacement are essential in perioperative phases, multiple trauma, liver surgery, cardiopulmonary bypass, shock, and disseminated intravascular coagulation (DIC).
- AT III deficiency is influenced by disease severity and the liver's synthetic capacity.
- AT III replacement effectively prevents severe thromboembolic complications.
Conclusions:
- Maintaining adequate AT III levels is critical for preventing thromboembolic complications in high-risk patients.
- AT III replacement therapy is a key intervention in managing AT III deficiency.
- Proactive AT III management can significantly improve patient outcomes and prevent life-threatening events.